Dr. James Chappell, MD

NPI: 1598726440
Total Payments
$538,342
2024 Payments
$55,713
Companies
21
Transactions
1,300

Payment Breakdown by Category

Other$470,525 (87.4%)
Travel$36,331 (6.7%)
Consulting$17,469 (3.2%)
Food & Beverage$13,906 (2.6%)
Education$110.46 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $470,525 468 87.4%
Travel and Lodging $36,331 317 6.7%
Consulting Fee $17,469 9 3.2%
Food and Beverage $13,906 498 2.6%
Education $110.46 8 0.0%

Top Paying Companies

Company Total Records Latest Year
Lilly USA, LLC $471,535 1,075 $0 (2024)
AstraZeneca Pharmaceuticals LP $41,918 95 $0 (2022)
Boehringer Ingelheim Pharmaceuticals, Inc. $22,886 46 $0 (2022)
Novo Nordisk Inc $401.51 7 $0 (2024)
Medtronic, Inc. $309.96 24 $0 (2023)
Medtronic MiniMed, Inc. $214.58 10 $0 (2020)
ABBVIE INC. $194.20 10 $0 (2024)
Kowa Pharmaceuticals America, Inc. $189.68 11 $0 (2022)
Amgen Inc. $172.44 4 $0 (2022)
Rhythm Pharmaceuticals, Inc. $148.36 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $55,713 128 Lilly USA, LLC ($55,416)
2023 $54,597 146 Lilly USA, LLC ($54,205)
2022 $46,238 112 Lilly USA, LLC ($45,801)
2021 $32,548 88 Lilly USA, LLC ($27,680)
2020 $69,750 157 Lilly USA, LLC ($63,428)
2019 $100,437 249 Lilly USA, LLC ($95,658)
2018 $73,963 154 Lilly USA, LLC ($45,830)
2017 $105,096 266 Lilly USA, LLC ($83,518)

All Payment Transactions

1,300 individual payment records from CMS Open Payments — Page 1 of 52

Date Company Product Nature Form Amount Type
12/02/2024 Lilly USA, LLC MOUNJARO (Drug) Travel and Lodging Cash or cash equivalent $34.84 General
Category: Diabetes
12/02/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $21.60 General
Category: Diabetes
12/02/2024 Lilly USA, LLC MOUNJARO (Drug) Travel and Lodging Cash or cash equivalent $18.00 General
Category: Diabetes
12/02/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $16.60 General
Category: Diabetes
12/02/2024 Lilly USA, LLC MOUNJARO (Drug) Travel and Lodging Cash or cash equivalent $7.32 General
Category: Diabetes
12/02/2024 Lilly USA, LLC MOUNJARO (Drug) Travel and Lodging Cash or cash equivalent $6.80 General
Category: Diabetes
11/26/2024 Lilly USA, LLC MOUNJARO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,400.00 General
Category: Diabetes
11/26/2024 Lilly USA, LLC MOUNJARO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,225.00 General
Category: Diabetes
11/21/2024 Lilly USA, LLC Travel and Lodging In-kind items and services $421.99 General
11/21/2024 Lilly USA, LLC Travel and Lodging In-kind items and services $150.27 General
11/21/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $112.10 General
Category: Diabetes
11/15/2024 Lilly USA, LLC MOUNJARO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,400.00 General
Category: Diabetes
11/15/2024 Lilly USA, LLC MOUNJARO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $525.00 General
Category: Diabetes
11/15/2024 Lilly USA, LLC MOUNJARO (Drug) Travel and Lodging Cash or cash equivalent $3.62 General
Category: Diabetes
11/12/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $15.45 General
Category: Diabetes
10/30/2024 Lilly USA, LLC MOUNJARO (Drug) Travel and Lodging Cash or cash equivalent $13.40 General
Category: Diabetes
10/29/2024 Lilly USA, LLC MOUNJARO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,400.00 General
Category: Diabetes
10/29/2024 Lilly USA, LLC MOUNJARO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $525.00 General
Category: Diabetes
10/26/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $21.60 General
Category: Diabetes
10/24/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $97.50 General
Category: Diabetes
10/24/2024 Lilly USA, LLC MOUNJARO (Drug) Travel and Lodging Cash or cash equivalent $54.00 General
Category: Diabetes
10/24/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $46.94 General
Category: Diabetes
10/24/2024 Lilly USA, LLC MOUNJARO (Drug) Travel and Lodging Cash or cash equivalent $41.54 General
Category: Diabetes
10/24/2024 Lilly USA, LLC MOUNJARO (Drug) Travel and Lodging Cash or cash equivalent $32.09 General
Category: Diabetes
10/24/2024 Lilly USA, LLC MOUNJARO (Drug) Travel and Lodging Cash or cash equivalent $13.40 General
Category: Diabetes

About Dr. James Chappell, MD

Dr. James Chappell, MD is a Specialist healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598726440.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Chappell, MD has received a total of $538,342 in payments from pharmaceutical and medical device companies, with $55,713 received in 2024. These payments were reported across 1,300 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($470,525).

Practice Information

  • Specialty Specialist
  • Location Denver, CO
  • Active Since 03/30/2006
  • Last Updated 10/26/2007
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1598726440

Products in Payments

  • TRULICITY (Drug) $254,163
  • MOUNJARO (Drug) $143,849
  • JARDIANCE (Drug) $70,510
  • FARXIGA (Drug) $31,429
  • BYDUREON (Drug) $10,323
  • Minimed 670G System (Device) $203.21
  • Livalo (Drug) $189.68
  • SYNTHROID (Drug) $172.99
  • IMCIVREE (Drug) $148.36
  • INTRAROSA (Drug) $124.41
  • BYETTA (Drug) $123.85
  • Prolia (Biological) $120.65
  • MINIMED 780G (Device) $101.51
  • Minimed 770G System (Device) $79.82
  • MINIMED 770G (Device) $71.67
  • Tirosint (Drug) $49.45
  • InPen (Device) $48.39
  • JANUVIA (Drug) $47.95
  • EVENITY (Biological) $37.90
  • Dexcom G6 Transmitter (Medical Supply) $35.16

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Denver